News Industry News MHRA review confirms benefit-risk profile of Alteplase - the only licensed clot buster for acute ischaemic stroke July 24, 2015
News Industry News American Heart Association's New Stroke Treatment Guidelines Establish Stent Retrievers as First-Line Endovascular Treatment for Acute Ischemic Stroke June 30, 2015
News Industry News Pre-Clinical Study Conducted at Mayo Clinic LOS ANGELES, NeuroSigma®, Inc. (NeuroSigma), a California-based life sciences company, today announced that results of an animal study of its Thin Film Nit May 04, 2015
News Industry News NSVascular, Inc., a NeuroSigma Subsidiary, Signs an Exclusive License Covering UCLA's Thin-Film Nitinol (TFN) Stent Technology for Endovascular Applications July 18, 2011